Cargando…

Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance

BACKGROUND: In the two fibrotic hypersensitivity pneumonitis (fHP) diagnostic guidelines, the multidisciplinary discussion (MDD) is required to be performed in diagnosis of fHP, as in idiopathic pulmonary fibrosis (IPF) diagnostic guideline. Although some patients with fHP can improve disease condit...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuda, Ryo, Takemura, Tamiko, Misumi, Toshihiro, Hagiwara, Eri, Ogura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166106/
https://www.ncbi.nlm.nih.gov/pubmed/37168674
http://dx.doi.org/10.2147/JAA.S409042
_version_ 1785038376634679296
author Okuda, Ryo
Takemura, Tamiko
Misumi, Toshihiro
Hagiwara, Eri
Ogura, Takashi
author_facet Okuda, Ryo
Takemura, Tamiko
Misumi, Toshihiro
Hagiwara, Eri
Ogura, Takashi
author_sort Okuda, Ryo
collection PubMed
description BACKGROUND: In the two fibrotic hypersensitivity pneumonitis (fHP) diagnostic guidelines, the multidisciplinary discussion (MDD) is required to be performed in diagnosis of fHP, as in idiopathic pulmonary fibrosis (IPF) diagnostic guideline. Although some patients with fHP can improve disease condition during antigen avoidance, which can facilitate the diagnosis of fHP, it is unclear if MDD is necessary in all patients with suspected fHP who improved an antigen avoidance. OBJECTIVE: To investigate the diagnosis of fHP via MDD with positive antigen avoidance tests (AATs) and the clinical diagnosis with positive AATs. METHODS: A single-center, retrospective study was conducted. Between 2012 and 2019, patients with fHP were enrolled in the study. Patients in the MDD diagnostic group consisted of patients diagnosed with MDD, including histopathology findings and positive ATTs, and patients in the clinical diagnostic group were diagnosed by two respiratory physicians and had positive ATTs. RESULTS: AAT was performed on 72 of 219 patients, and 58 had positive AATs. The study included 37 patients in the MDD diagnosis group and 21 patients in the clinical diagnosis group. No significant differences in overall survival (OS) were detected between the two groups (HR: 1.99 [95% CI: 0.82‒4.83], p = 0.127). The conducting MDD was not a risk factor for OS; only <79% forced vital capacity was a risk factor in the multivariate Cox hazard regression analysis. No significant difference in annual changes of forced vital capacity, diffusion of the lung for carbon monoxide and Krebs von den Lungen-6 between the MDD diagnostic and the clinical diagnostic groups were observed (p = 0.41, 0.79, and 0.81, respectively). CONCLUSION: In patients with positive AATs, the disease progression of the MDD diagnostic and the clinical diagnostic groups were similar. Therefore, MDD could not be necessary in all patients with suspected fHP who had positive AATs.
format Online
Article
Text
id pubmed-10166106
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-101661062023-05-09 Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance Okuda, Ryo Takemura, Tamiko Misumi, Toshihiro Hagiwara, Eri Ogura, Takashi J Asthma Allergy Original Research BACKGROUND: In the two fibrotic hypersensitivity pneumonitis (fHP) diagnostic guidelines, the multidisciplinary discussion (MDD) is required to be performed in diagnosis of fHP, as in idiopathic pulmonary fibrosis (IPF) diagnostic guideline. Although some patients with fHP can improve disease condition during antigen avoidance, which can facilitate the diagnosis of fHP, it is unclear if MDD is necessary in all patients with suspected fHP who improved an antigen avoidance. OBJECTIVE: To investigate the diagnosis of fHP via MDD with positive antigen avoidance tests (AATs) and the clinical diagnosis with positive AATs. METHODS: A single-center, retrospective study was conducted. Between 2012 and 2019, patients with fHP were enrolled in the study. Patients in the MDD diagnostic group consisted of patients diagnosed with MDD, including histopathology findings and positive ATTs, and patients in the clinical diagnostic group were diagnosed by two respiratory physicians and had positive ATTs. RESULTS: AAT was performed on 72 of 219 patients, and 58 had positive AATs. The study included 37 patients in the MDD diagnosis group and 21 patients in the clinical diagnosis group. No significant differences in overall survival (OS) were detected between the two groups (HR: 1.99 [95% CI: 0.82‒4.83], p = 0.127). The conducting MDD was not a risk factor for OS; only <79% forced vital capacity was a risk factor in the multivariate Cox hazard regression analysis. No significant difference in annual changes of forced vital capacity, diffusion of the lung for carbon monoxide and Krebs von den Lungen-6 between the MDD diagnostic and the clinical diagnostic groups were observed (p = 0.41, 0.79, and 0.81, respectively). CONCLUSION: In patients with positive AATs, the disease progression of the MDD diagnostic and the clinical diagnostic groups were similar. Therefore, MDD could not be necessary in all patients with suspected fHP who had positive AATs. Dove 2023-05-04 /pmc/articles/PMC10166106/ /pubmed/37168674 http://dx.doi.org/10.2147/JAA.S409042 Text en © 2023 Okuda et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Okuda, Ryo
Takemura, Tamiko
Misumi, Toshihiro
Hagiwara, Eri
Ogura, Takashi
Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
title Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
title_full Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
title_fullStr Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
title_full_unstemmed Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
title_short Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
title_sort multidisciplinary discussion for fibrotic hypersensitivity pneumonitis with a positive antigen avoidance
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166106/
https://www.ncbi.nlm.nih.gov/pubmed/37168674
http://dx.doi.org/10.2147/JAA.S409042
work_keys_str_mv AT okudaryo multidisciplinarydiscussionforfibrotichypersensitivitypneumonitiswithapositiveantigenavoidance
AT takemuratamiko multidisciplinarydiscussionforfibrotichypersensitivitypneumonitiswithapositiveantigenavoidance
AT misumitoshihiro multidisciplinarydiscussionforfibrotichypersensitivitypneumonitiswithapositiveantigenavoidance
AT hagiwaraeri multidisciplinarydiscussionforfibrotichypersensitivitypneumonitiswithapositiveantigenavoidance
AT oguratakashi multidisciplinarydiscussionforfibrotichypersensitivitypneumonitiswithapositiveantigenavoidance